Challenges in targeting TNFalpha in asthma and COPD

Current Opinion in Investigational Drugs

Volumn 10, Issue 5, 2009, Pages 404-406

  Antoniu, S A ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CD4 ANTIGEN; CORTICOSTEROID; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIASTHMATIC AGENT;

ADD ON THERAPY; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATING ACTIVITY; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; EDITORIAL; EOSINOPHIL; HUMAN; INFECTION COMPLICATION; INFLAMMATION; INJECTION SITE REACTION; PHENOTYPE; RASH; RESPIRATORY TRACT INFECTION; SIDE EFFECT; TH2 CELL; ANIMAL; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL TRIALS AS TOPIC; DRUG DELIVERY SYSTEMS; HUMANS; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67649386199     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma, Gaithersburg, MD, USA (2008). www.ginasthma.com/ Guidelineitem.aspl1=2&l2=1&irrntId=60
2. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease, Gaithersburg, MD, USA (2008). wrww.goldcopd.org/ Guidelineitem. asp?l1=2&l2=1&intId=2003
3. Antoniu SA, Mihaltan F, Ulmeanu R: Anti-TNF-α therapies in chronic obstructive pulmonary diseases. Expert Opin Investig Drugs (2008) 17(8):1203-1211.
4. Mukhopadhyay S, Hoidal JR, Mukherjee TK: Role of TNFα in pulmonary pathophysiology. Respir Res (2006) 7(1):125.
5. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, Bradding P, Brightling CE, Wardlaw AJ, Pavord ID: Evidence of a role of tumor necrosis factor α in refractory asthma. N Engl J Med (2006) 354(7):697-708.
6. Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnell W, Beckett P, Al Ali M, Chauhan A, Wilson SJ, Reynolds A et al: Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 60(12):1012-1018.
7. Silvestri M, Bontempelli M, Giacomelli M, Malerba M, Rossi GA, Di Stefano A, Rossi A, Ricciardolo FL: High serum levels of tumour necrosis factor-α and interleukin-8 in severe asthma: Markers of systemic inflammation? Clin Exp Allergy (2006) 36(11):1373-1381.
8. Di Francia M, Barbier D, Mege Jl, Orehek J: Tumor necrosis factor- levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1994) 150 (5 Pt 1):1453-1455.
9. Hutchison S, Choo-Kang BS, Bundick RV, Leishman AJ, Brewer JM, McInnes IB, Garside P: Tumour necrosis factor-α blockade suppresses murine allergic airways inflammation. Clin Exp Immunol (2008) 151(1):114-122.
10. Suissa S, Ernst P, Hudson M: TNF-α antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease. Pulm Pharmacol Ther (2008) 21(1):234-238.
11. Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, Mahler D, Saadeh C, Slier T, Snell P, Korenblat P et al: The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 175(9):926-934.
12. Erin EM, Leaker BR, Nicholson GC, Tan AJ, Green LM, Neighbour H, Zacharasiewicz AS, Turner J, Barnathan ES, Kon OM, Barnes PJ, Hansel TT: The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med (2006) 174(7):753-762.
13. Wenzel SE, Barnes PJ, Bleecker ER, Bousquet J, Busse W, Dahlén SE, Holgate ST, Meyers DA, Rabe KF, Antczak A, Baker J et al: A randomized, double-blind, placebo-controlled study of tumor necrosis factor-α blockade in severe persistent asthma. Am J Respir Crit Care Med (2009) 179(7):549-558.
14. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO: Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis (2004) 38(9):1261-1265.